Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Fidia Spa ( (IT:FDA) ) has issued an update.
Fidia S.p.A. has announced the termination of employment with its CFO, Dr. Luca Carante, as part of a strategic move to strengthen its organizational structure. The company is actively seeking a new candidate for the CFO and Investor Relations Manager roles, with interim responsibilities being handled by the CEO and Chairman.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.50 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A. is a global leader in the design, production, and marketing of high-performance integrated milling systems, primarily serving the automotive and aerospace sectors. With over 50 years of experience, the company offers comprehensive solutions for the entire milling process, including numerical controls, high-speed milling systems, and CAM software.
Average Trading Volume: 440,111
Technical Sentiment Signal: Strong Sell
Current Market Cap: €1.71M
Learn more about FDA stock on TipRanks’ Stock Analysis page.